Endovia Health Sciences Files 8‑K, Issues Press Release Under Regulation FD

What Happened

• Endovia Health Sciences, Inc. (EDVA) filed a Current Report on Form 8‑K on September 22, 2026 to disclose that the company issued a press release announcing certain developments.
• The press release is furnished as Exhibit 99.1 to the 8‑K; the filing also includes the Cover Page Interactive Data File (Exhibit 104, Inline XBRL).

Key Details

• Filing date: September 22, 2026.
• Reported items: Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
• Exhibit included: Exhibit 99.1 — Press Release dated September 22, 2026.
• Exhibit 104: Cover Page Interactive Data File embedded as Inline XBRL.

Why It Matters

• The 8‑K confirms the company publicly released new information via a press release (Regulation FD), so any material developments referenced in that release are now broadly disclosed to investors.
• The 8‑K itself does not present financial statements or management changes beyond furnishing the press release; investors should read Exhibit 99.1 for the substantive details and watch for any follow‑up filings (e.g., future 8‑Ks or 10‑Q/10‑K) if the release references financial results or corporate actions.